Research ArticleArticle
Pharmacokinetic Study of the Structural Components of Adenosine Diphosphate-Encapsulated Liposomes Coated with Fibrinogen γ-Chain Dodecapeptide as a Synthetic Platelet Substitute
Kazuaki Taguchi, Hayato Ujihira, Shigeru Ogaki, Hiroshi Watanabe, Atsushi Fujiyama, Mami Doi, Yosuke Okamura, Shinji Takeoka, Yasuo Ikeda, Makoto Handa, Masaki Otagiri and Toru Maruyama
Drug Metabolism and Disposition August 2013, 41 (8) 1584-1591; DOI: https://doi.org/10.1124/dmd.112.050005
Kazuaki Taguchi
Department of Biopharmaceutics, Graduate School of Pharmaceutical Sciences (K.T., H.U., S.O., H.W., M.O., T.M.), and Center for Clinical Pharmaceutical Sciences (H.W., T.M.), Kumamoto University, Kumamoto, Japan; Department of Life Science and Medical Bioscience, Graduate School of Advanced Science and Engineering, Waseda University, Tokyo, Japan (A.F., M.D., S.T., Y.I); Institute of Innovative Science and Technology, Tokai University, Tokyo, Japan (Y.O.); Department of Transfusion Medicine & Cell Therapy, Keio University, Tokyo, Japan (M.H.); and Faculty of Pharmaceutical Sciences and DDS Research Institute, Sojo University, Kumamoto, Japan (M.O.)
Hayato Ujihira
Department of Biopharmaceutics, Graduate School of Pharmaceutical Sciences (K.T., H.U., S.O., H.W., M.O., T.M.), and Center for Clinical Pharmaceutical Sciences (H.W., T.M.), Kumamoto University, Kumamoto, Japan; Department of Life Science and Medical Bioscience, Graduate School of Advanced Science and Engineering, Waseda University, Tokyo, Japan (A.F., M.D., S.T., Y.I); Institute of Innovative Science and Technology, Tokai University, Tokyo, Japan (Y.O.); Department of Transfusion Medicine & Cell Therapy, Keio University, Tokyo, Japan (M.H.); and Faculty of Pharmaceutical Sciences and DDS Research Institute, Sojo University, Kumamoto, Japan (M.O.)
Shigeru Ogaki
Department of Biopharmaceutics, Graduate School of Pharmaceutical Sciences (K.T., H.U., S.O., H.W., M.O., T.M.), and Center for Clinical Pharmaceutical Sciences (H.W., T.M.), Kumamoto University, Kumamoto, Japan; Department of Life Science and Medical Bioscience, Graduate School of Advanced Science and Engineering, Waseda University, Tokyo, Japan (A.F., M.D., S.T., Y.I); Institute of Innovative Science and Technology, Tokai University, Tokyo, Japan (Y.O.); Department of Transfusion Medicine & Cell Therapy, Keio University, Tokyo, Japan (M.H.); and Faculty of Pharmaceutical Sciences and DDS Research Institute, Sojo University, Kumamoto, Japan (M.O.)
Hiroshi Watanabe
Department of Biopharmaceutics, Graduate School of Pharmaceutical Sciences (K.T., H.U., S.O., H.W., M.O., T.M.), and Center for Clinical Pharmaceutical Sciences (H.W., T.M.), Kumamoto University, Kumamoto, Japan; Department of Life Science and Medical Bioscience, Graduate School of Advanced Science and Engineering, Waseda University, Tokyo, Japan (A.F., M.D., S.T., Y.I); Institute of Innovative Science and Technology, Tokai University, Tokyo, Japan (Y.O.); Department of Transfusion Medicine & Cell Therapy, Keio University, Tokyo, Japan (M.H.); and Faculty of Pharmaceutical Sciences and DDS Research Institute, Sojo University, Kumamoto, Japan (M.O.)
Atsushi Fujiyama
Department of Biopharmaceutics, Graduate School of Pharmaceutical Sciences (K.T., H.U., S.O., H.W., M.O., T.M.), and Center for Clinical Pharmaceutical Sciences (H.W., T.M.), Kumamoto University, Kumamoto, Japan; Department of Life Science and Medical Bioscience, Graduate School of Advanced Science and Engineering, Waseda University, Tokyo, Japan (A.F., M.D., S.T., Y.I); Institute of Innovative Science and Technology, Tokai University, Tokyo, Japan (Y.O.); Department of Transfusion Medicine & Cell Therapy, Keio University, Tokyo, Japan (M.H.); and Faculty of Pharmaceutical Sciences and DDS Research Institute, Sojo University, Kumamoto, Japan (M.O.)
Mami Doi
Department of Biopharmaceutics, Graduate School of Pharmaceutical Sciences (K.T., H.U., S.O., H.W., M.O., T.M.), and Center for Clinical Pharmaceutical Sciences (H.W., T.M.), Kumamoto University, Kumamoto, Japan; Department of Life Science and Medical Bioscience, Graduate School of Advanced Science and Engineering, Waseda University, Tokyo, Japan (A.F., M.D., S.T., Y.I); Institute of Innovative Science and Technology, Tokai University, Tokyo, Japan (Y.O.); Department of Transfusion Medicine & Cell Therapy, Keio University, Tokyo, Japan (M.H.); and Faculty of Pharmaceutical Sciences and DDS Research Institute, Sojo University, Kumamoto, Japan (M.O.)
Yosuke Okamura
Department of Biopharmaceutics, Graduate School of Pharmaceutical Sciences (K.T., H.U., S.O., H.W., M.O., T.M.), and Center for Clinical Pharmaceutical Sciences (H.W., T.M.), Kumamoto University, Kumamoto, Japan; Department of Life Science and Medical Bioscience, Graduate School of Advanced Science and Engineering, Waseda University, Tokyo, Japan (A.F., M.D., S.T., Y.I); Institute of Innovative Science and Technology, Tokai University, Tokyo, Japan (Y.O.); Department of Transfusion Medicine & Cell Therapy, Keio University, Tokyo, Japan (M.H.); and Faculty of Pharmaceutical Sciences and DDS Research Institute, Sojo University, Kumamoto, Japan (M.O.)
Shinji Takeoka
Department of Biopharmaceutics, Graduate School of Pharmaceutical Sciences (K.T., H.U., S.O., H.W., M.O., T.M.), and Center for Clinical Pharmaceutical Sciences (H.W., T.M.), Kumamoto University, Kumamoto, Japan; Department of Life Science and Medical Bioscience, Graduate School of Advanced Science and Engineering, Waseda University, Tokyo, Japan (A.F., M.D., S.T., Y.I); Institute of Innovative Science and Technology, Tokai University, Tokyo, Japan (Y.O.); Department of Transfusion Medicine & Cell Therapy, Keio University, Tokyo, Japan (M.H.); and Faculty of Pharmaceutical Sciences and DDS Research Institute, Sojo University, Kumamoto, Japan (M.O.)
Yasuo Ikeda
Department of Biopharmaceutics, Graduate School of Pharmaceutical Sciences (K.T., H.U., S.O., H.W., M.O., T.M.), and Center for Clinical Pharmaceutical Sciences (H.W., T.M.), Kumamoto University, Kumamoto, Japan; Department of Life Science and Medical Bioscience, Graduate School of Advanced Science and Engineering, Waseda University, Tokyo, Japan (A.F., M.D., S.T., Y.I); Institute of Innovative Science and Technology, Tokai University, Tokyo, Japan (Y.O.); Department of Transfusion Medicine & Cell Therapy, Keio University, Tokyo, Japan (M.H.); and Faculty of Pharmaceutical Sciences and DDS Research Institute, Sojo University, Kumamoto, Japan (M.O.)
Makoto Handa
Department of Biopharmaceutics, Graduate School of Pharmaceutical Sciences (K.T., H.U., S.O., H.W., M.O., T.M.), and Center for Clinical Pharmaceutical Sciences (H.W., T.M.), Kumamoto University, Kumamoto, Japan; Department of Life Science and Medical Bioscience, Graduate School of Advanced Science and Engineering, Waseda University, Tokyo, Japan (A.F., M.D., S.T., Y.I); Institute of Innovative Science and Technology, Tokai University, Tokyo, Japan (Y.O.); Department of Transfusion Medicine & Cell Therapy, Keio University, Tokyo, Japan (M.H.); and Faculty of Pharmaceutical Sciences and DDS Research Institute, Sojo University, Kumamoto, Japan (M.O.)
Masaki Otagiri
Department of Biopharmaceutics, Graduate School of Pharmaceutical Sciences (K.T., H.U., S.O., H.W., M.O., T.M.), and Center for Clinical Pharmaceutical Sciences (H.W., T.M.), Kumamoto University, Kumamoto, Japan; Department of Life Science and Medical Bioscience, Graduate School of Advanced Science and Engineering, Waseda University, Tokyo, Japan (A.F., M.D., S.T., Y.I); Institute of Innovative Science and Technology, Tokai University, Tokyo, Japan (Y.O.); Department of Transfusion Medicine & Cell Therapy, Keio University, Tokyo, Japan (M.H.); and Faculty of Pharmaceutical Sciences and DDS Research Institute, Sojo University, Kumamoto, Japan (M.O.)
Toru Maruyama
Department of Biopharmaceutics, Graduate School of Pharmaceutical Sciences (K.T., H.U., S.O., H.W., M.O., T.M.), and Center for Clinical Pharmaceutical Sciences (H.W., T.M.), Kumamoto University, Kumamoto, Japan; Department of Life Science and Medical Bioscience, Graduate School of Advanced Science and Engineering, Waseda University, Tokyo, Japan (A.F., M.D., S.T., Y.I); Institute of Innovative Science and Technology, Tokai University, Tokyo, Japan (Y.O.); Department of Transfusion Medicine & Cell Therapy, Keio University, Tokyo, Japan (M.H.); and Faculty of Pharmaceutical Sciences and DDS Research Institute, Sojo University, Kumamoto, Japan (M.O.)
DMD articles become freely available 12 months after publication, and remain freely available for 5 years.Non-open access articles that fall outside this five year window are available only to institutional subscribers and current ASPET members, or through the article purchase feature at the bottom of the page.
|
Log in using your username and password
Purchase access
You may purchase access to this article. This will require you to create an account if you don't already have one.
In this issue
Research ArticleArticle
Disposition of H12-(ADP)-Liposomes
Kazuaki Taguchi, Hayato Ujihira, Shigeru Ogaki, Hiroshi Watanabe, Atsushi Fujiyama, Mami Doi, Yosuke Okamura, Shinji Takeoka, Yasuo Ikeda, Makoto Handa, Masaki Otagiri and Toru Maruyama
Drug Metabolism and Disposition August 1, 2013, 41 (8) 1584-1591; DOI: https://doi.org/10.1124/dmd.112.050005
Research ArticleArticle
Disposition of H12-(ADP)-Liposomes
Kazuaki Taguchi, Hayato Ujihira, Shigeru Ogaki, Hiroshi Watanabe, Atsushi Fujiyama, Mami Doi, Yosuke Okamura, Shinji Takeoka, Yasuo Ikeda, Makoto Handa, Masaki Otagiri and Toru Maruyama
Drug Metabolism and Disposition August 1, 2013, 41 (8) 1584-1591; DOI: https://doi.org/10.1124/dmd.112.050005
Jump to section
Related Articles
Cited By...
More in this TOC Section
Similar Articles
Advertisement